
4519 · Chugai Pharmaceutical Co., Ltd.
7011.00
JPYUnlock stock Insights
Create a free account to unlock price targets, recommendations, and commentary.
Overview
Market Cap
JPY11.92T
PE
31.30
EV/EBITDA
20.2
DIV Yield
3.3%
Payout Ratio
103%
MQV Rating
4Weak
As at 21/08/2026 12:00:00 AM
Price Chart
Description
- All-Companies
- All-Consensus
- Consensus Cheap
- HALO 200
- HALO 500
- HALO All
- HALO Balance Sheet
- HALO Capital Efficiency
- HALO Consensus Value
Key Fundamentals
EPS 3 yr Growth
15.90%
EBITDA Margin
49.60%
Operating Cashflow
¥389,451m
Free Cash Flow Return
19.70%
ROIC
22.00%
Interest Coverage
NaN
Quick Ratio
3.60
Performance
52 weeks range
Low 6002 - 10700
Trade Value (12mth)
US$32,802,384.00
1 week
-1.03%
1 month
-2.81%
YTD
-16.62%
1 year
16.56%
All time high
10700.00
Additional Data
Shares Outstanding (Fully Diluted)
1,646m
HALO Sector
Healthcare
Next Company Report Date
04-Feb-27
Next Ex Dividend Date
29-Dec-26
Next Dividend Pay Date
29-Dec-26
Reporting Currency
JPY
Short Sell (% of issue)
0.00
Health Scores
Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Halo Model
Mqv
Weak
Garp
Strong
Mqv Small
Neutral
Momentum
Price
Very Weak
Earnings
Very Weak
Growth
Earnings
Neutral
Dividends
Weak
Quality
Capital Efficiency
Very Strong
Balance Sheet
Very Strong
Valuation
News & Announcements
No announcements available.
Key Stakeholders
| Name | Title |
| Roche Holding AG | Public Company |
| Chugai Pharmaceutical Co., Ltd. | Public Company |
| Sumitomo Life Insurance Co. | Private Company |
| Tokio Marine Holdings, Inc. | Public Company |
| Sompo Holdings, Inc. | Public Company |